Use of leflunomide in human renal transplantation

Transplantation

Volumn 72, Issue 10, 2001, Pages 1709-

  Pascual, J ^a   Orte, J ^a   Marcen R ^a   Burgos, J ^a   Ortuno J ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID; TACROLIMUS;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DIARRHEA; DISEASE COURSE; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LETTER; NEPHROTIC SYNDROME; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

EID: 0035960685     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200111270-00026     Document Type: Letter

References (4)

1. Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis: Results of a randomized, placebo-controlled, phase II study
2. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial
3. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide
4. Efficacy of FK506, leflunomide, anti-CD4 and CTLA4Ig treatments in rat to mouse pancreas xenograft transplantation